haloperidol &#160; Turanci (Q251347)

https://www.whocc.no/atc_ddd_index/?code=N05AD01

8 milligram

route of administration ^Turanci

parenteral route of administration ^Turanci

1 reference

https://www.whocc.no/atc_ddd_index/?code=N05AD01

3.3 milligram

route of administration ^Turanci

parenteral route of administration ^Turanci

1 reference

https://www.whocc.no/atc_ddd_index/?code=N05AD01

active ingredient in ^Turanci

Haldol ^Turanci

1 reference

stated in ^Turanci

RxNorm ^Turanci

RxNorm ID ^Turanci

151839

retrieved ^Turanci

14 Faburairu 2018

World Health Organisation international non-proprietary name ^Turanci

haloperidol (Turanci)

1 reference

stated in ^Turanci

Recommended INN: List 4 ^Turanci

medical condition treated ^Turanci

schizophreniform disorder ^Turanci

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

retrieved ^Turanci

13 Disamba 2016

Tourette syndrome ^Turanci

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

retrieved ^Turanci

13 Disamba 2016

amai

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

retrieved ^Turanci

13 Disamba 2016

Hauka

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

retrieved ^Turanci

13 Disamba 2016

psychosis ^Turanci

1 reference

stated in ^Turanci

retrieved ^Turanci

2 Oktoba 2018

schizoaffective disorder ^Turanci

1 reference

stated in ^Turanci

retrieved ^Turanci

2 Oktoba 2018

mental disorder ^Turanci

1 reference

stated in ^Turanci

retrieved ^Turanci

2 Oktoba 2018

anxiety

1 reference

stated in ^Turanci

retrieved ^Turanci

2 Oktoba 2018

Delirium ^Turanci

0 references

significant drug interaction ^Turanci

amiodarone ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

anagrelide ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

arsenic trioxide ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

astemizole ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

azithromycin ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

bepridil ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

chloroquine ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

chlorpromazine ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

cisapride ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

(RS)-citalopram ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

clarithromycin ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

cocaine ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

disopyramide ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

dofetilide ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

domperidone ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

dronedarone ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

droperidol ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

erythromycin ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

escitalopram ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

flecainide ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

halofantrine ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

ibutilide ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

mesoridazine ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

(RS)-methadone ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

moxifloxacin ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

ondansetron ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

pentamidine ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

pimozide ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

probucol ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

procainamide ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

quinidine ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

sevoflurane ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

sotalol ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

sparfloxacin ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

(RS)-sulpiride ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

terfenadine ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

thioridazine ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

amiodarone ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

disopyramide ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

erythromycin ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

chlorpromazine ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

risperidone ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

ondansetron ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

clomipramine ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

apomorphine ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

pimozide ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

anagrelide ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

moxifloxacin ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

dronedarone ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

crizotinib ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

zuclopenthixol ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

pasireotide ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

paliperidone ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

(RS)-hydroxyzine ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

(RS)-citalopram ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

(RS)-sulpiride ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

(RS)-methadone ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

vandetanib ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

clarithromycin ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

droperidol ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

arsenic trioxide ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

pentamidine ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

mefloquine ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

loxapine ^Turanci

hypotension ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

propranolol ^Turanci

hypotension ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

domperidone ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

fingolimod ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

toremifene ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

sotalol ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

lithium ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

tetrabenazine ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

ivabradine ^Turanci

torsades de pointes ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

paliperidone ^Turanci

hypotension ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

trimipramine ^Turanci

hypotension ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

amitriptyline ^Turanci

hypotension ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

bromocriptine ^Turanci

hypotension ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

risperidone ^Turanci

hypotension ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

(E/Z)-doxepin ^Turanci

hypotension ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

droperidol ^Turanci

hypotension ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

pimozide ^Turanci

hypotension ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

aripiprazole ^Turanci

hypotension ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

(−)-selegiline ^Turanci

hypotension ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

methyldopa ^Turanci

hypotension ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

sotalol ^Turanci

hypotension ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

clonidine ^Turanci

hypotension ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

cabergoline ^Turanci

hypotension ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

zuclopenthixol ^Turanci

hypotension ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

periciazine ^Turanci

hypotension ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

(RS)-sulpiride ^Turanci

hypotension ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

quetiapine ^Turanci

hypotension ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

imipramine ^Turanci

hypotension ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

olanzapine ^Turanci

hypotension ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

levodopa ^Turanci

hypotension ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

chlorpromazine ^Turanci

hypotension ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

clomipramine ^Turanci

hypotension ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

clozapine ^Turanci

hypotension ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

apomorphine ^Turanci

hypotension ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

amiodarone ^Turanci

torsades de pointes ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

trimipramine ^Turanci

torsades de pointes ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

trimipramine ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

trimipramine ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

trimipramine ^Turanci

cardiotoxicity ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

amitriptyline ^Turanci

torsades de pointes ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

amitriptyline ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

amitriptyline ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

amitriptyline ^Turanci

cardiotoxicity ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

(E/Z)-doxepin ^Turanci

torsades de pointes ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

(E/Z)-doxepin ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

(E/Z)-doxepin ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

(E/Z)-doxepin ^Turanci

cardiotoxicity ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

disopyramide ^Turanci

torsades de pointes ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

disopyramide ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

disopyramide ^Turanci

cardiotoxicity ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

erythromycin ^Turanci

torsades de pointes ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

erythromycin ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

erythromycin ^Turanci

cardiotoxicity ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

mefloquine ^Turanci

torsades de pointes ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

mefloquine ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

mefloquine ^Turanci

cardiotoxicity ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

imipramine ^Turanci

torsades de pointes ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

imipramine ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

imipramine ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

imipramine ^Turanci

cardiotoxicity ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

chlorpromazine ^Turanci

torsades de pointes ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

chlorpromazine ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

chlorpromazine ^Turanci

cardiotoxicity ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

(±)-promethazine ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

toremifene ^Turanci

torsades de pointes ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

sotalol ^Turanci

torsades de pointes ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

quetiapine ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

ivabradine ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

clozapine ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

aripiprazole ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

(RS)-sulpiride ^Turanci

torsades de pointes ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

pethidine ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

pethidine ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

periciazine ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

Tramadol

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

Tramadol

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

morphine ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

morphine ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

oxycodone ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

oxycodone ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

hydromorphone ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

hydromorphone ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

dihydrocodeine ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

dihydrocodeine ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

codeine ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

codeine ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

tapentadol ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

tapentadol ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

(RS)-methadone ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

(RS)-methadone ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

vandetanib ^Turanci

torsades de pointes ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

buprenorphine ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

buprenorphine ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

fentanyl

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

alfentanil ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

alfentanil ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

alfentanil ^Turanci

hypotension ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

sufentanil ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

sufentanil ^Turanci

hypotension ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

lithium ^Turanci

extrapyramidal symptoms ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

lithium ^Turanci

encephalopathy ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

lithium ^Turanci

dyskinesia ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

lithium ^Turanci

asthenia ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

lithium ^Turanci

brain injury ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

loxapine ^Turanci

cognitive disorder ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

loxapine ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

loxapine ^Turanci

sedation ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

loxapine ^Turanci

syncope ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

droperidol ^Turanci

cardiotoxicity ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

droperidol ^Turanci

torsades de pointes ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

droperidol ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

pentamidine ^Turanci

cardiotoxicity ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

pentamidine ^Turanci

torsades de pointes ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

pentamidine ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

fluoxetine ^Turanci

torsades de pointes ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

fluoxetine ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

arsenic trioxide ^Turanci

torsades de pointes ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

propranolol ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

olanzapine ^Turanci

cogwheel rigidity ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

olanzapine ^Turanci

gait abnormality ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

ta jiki ma'amala da

5-hydroxytryptamine receptor 1A ^Turanci

subject has role ^Turanci

antagonist ^Turanci

1 reference

stated in ^Turanci

retrieved ^Turanci

17 Agusta 2016

5-hydroxytryptamine receptor 1D ^Turanci

subject has role ^Turanci

antagonist ^Turanci

1 reference

stated in ^Turanci

retrieved ^Turanci

17 Agusta 2016

5-hydroxytryptamine receptor 2A ^Turanci

subject has role ^Turanci

antagonist ^Turanci

2 references

stated in ^Turanci

retrieved ^Turanci

17 Agusta 2016

stated in ^Turanci

Open Targets Platform ^Turanci

retrieved ^Turanci

14 Agusta 2023

https://platform.opentargets.org/drug/CHEMBL54

5-hydroxytryptamine receptor 2B ^Turanci

subject has role ^Turanci

antagonist ^Turanci

1 reference

stated in ^Turanci

retrieved ^Turanci

17 Agusta 2016

5-hydroxytryptamine (serotonin) receptor 7 ^Turanci

subject has role ^Turanci

antagonist ^Turanci

1 reference

stated in ^Turanci

retrieved ^Turanci

17 Agusta 2016

5-hydroxytryptamine receptor 7 ^Turanci

subject has role ^Turanci

antagonist ^Turanci

1 reference

stated in ^Turanci

retrieved ^Turanci

17 Agusta 2016

Dopamine receptor D1 ^Turanci

subject has role ^Turanci

antagonist ^Turanci

1 reference

stated in ^Turanci

retrieved ^Turanci

17 Agusta 2016

dopamine receptor D2 ^Turanci

subject has role ^Turanci

antagonist ^Turanci

1 reference

stated in ^Turanci

retrieved ^Turanci

17 Agusta 2016

Dopamine receptor D3 ^Turanci

subject has role ^Turanci

antagonist ^Turanci

1 reference

stated in ^Turanci

retrieved ^Turanci

17 Agusta 2016

Dopamine receptor D4 ^Turanci

subject has role ^Turanci

antagonist ^Turanci

1 reference

stated in ^Turanci

retrieved ^Turanci

17 Agusta 2016

Dopamine receptor D5 ^Turanci

subject has role ^Turanci

antagonist ^Turanci

1 reference

stated in ^Turanci

retrieved ^Turanci

17 Agusta 2016

Histamine receptor H1 ^Turanci

subject has role ^Turanci

antagonist ^Turanci

1 reference

stated in ^Turanci

retrieved ^Turanci

17 Agusta 2016

Potassium inwardly-rectifying channel, subfamily J, member 6 ^Turanci

subject has role ^Turanci

antagonist ^Turanci

1 reference

stated in ^Turanci

retrieved ^Turanci

17 Agusta 2016

Potassium voltage-gated channel subfamily H member 1 ^Turanci

subject has role ^Turanci

antagonist ^Turanci

1 reference

stated in ^Turanci

retrieved ^Turanci

17 Agusta 2016

Dopamine receptor D4 ^Turanci

subject has role ^Turanci

inverse agonist ^Turanci

1 reference

stated in ^Turanci

Open Targets Platform ^Turanci

retrieved ^Turanci

14 Agusta 2023

https://platform.opentargets.org/drug/CHEMBL54

Dopamine receptor D3 ^Turanci

subject has role ^Turanci

inverse agonist ^Turanci

1 reference

stated in ^Turanci

Open Targets Platform ^Turanci

retrieved ^Turanci

14 Agusta 2023

https://platform.opentargets.org/drug/CHEMBL54

legal status (medicine) ^Turanci

boxed warning ^Turanci

1 reference

https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/343802

FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links. (Turanci)

pregnancy category ^Turanci

Australian pregnancy category C ^Turanci

1 reference

an ɗauko daga

English Wikipedia ^Turanci

US pregnancy category C ^Turanci

1 reference

an ɗauko daga

English Wikipedia ^Turanci

LiverTox likelihood score ^Turanci

LiverTox toxicity likelihood category B ^Turanci

1 reference

stated in ^Turanci

LiverTox ^Turanci

retrieved ^Turanci

8 Afirilu 2021

https://www.ncbi.nlm.nih.gov/books/n/livertox/Haloperidol

last update ^Turanci

25 Maris 2018

has characteristic ^Turanci

bitterness ^Turanci

1 reference

stated in ^Turanci

BitterDB ^Turanci

subject has role ^Turanci

dopamine antagonist ^Turanci

2 references

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

retrieved ^Turanci

5 Maris 2018

stated in ^Turanci

MeSH descriptor ID ^Turanci

retrieved ^Turanci

15 Maris 2018

antipsychotics ^Turanci

1 reference

stated in ^Turanci

MeSH descriptor ID ^Turanci

retrieved ^Turanci

15 Maris 2018

antiemetic ^Turanci

1 reference

stated in ^Turanci

MeSH descriptor ID ^Turanci

retrieved ^Turanci

15 Maris 2018

anti-dyskinesia agents ^Turanci

1 reference

stated in ^Turanci

MeSH descriptor ID ^Turanci

retrieved ^Turanci

15 Maris 2018

female reproductive toxicant ^Turanci

lokacin farawa

29 Janairu 1999

1 reference

stated in ^Turanci

California Proposition 65 list of chemicals ^Turanci

retrieved ^Turanci

26 Faburairu 2020

https://oehha.ca.gov/chemicals/haloperidol

developmental toxicant ^Turanci

lokacin farawa

29 Janairu 1999

1 reference

stated in ^Turanci

California Proposition 65 list of chemicals ^Turanci

retrieved ^Turanci

26 Faburairu 2020

https://oehha.ca.gov/chemicals/haloperidol

essential medicine ^Turanci

0 references

MCN code ^Turanci

2933.39.15

0 references

has part(s) ^Turanci

nitrogen ^Turanci

0 references

iskar shaƙa

0 references

fluorine ^Turanci

0 references

carbon ^Turanci

0 references

chlorine ^Turanci

0 references

Commons category ^Turanci

Haloperidol

0 references

Identifiers

InChI ^Turanci

InChI=1S/C21H23ClFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,26H,1-2,11-15H2

1 reference

stated in ^Turanci

PubChem ^Turanci

PubChem CID ^Turanci

haloperidol (Turanci)

retrieved ^Turanci

19 Nuwamba 2016

InChIKey ^Turanci

2 references

stated in ^Turanci

PubChem ^Turanci

PubChem CID ^Turanci

haloperidol (Turanci)

retrieved ^Turanci

19 Nuwamba 2016

stated in ^Turanci

ChEBI release 2020-09-01 ^Turanci

CAS Registry Number ^Turanci

52-86-8

2 references

stated in ^Turanci

UNII ^Turanci

haloperidol (Turanci)

retrieved ^Turanci

19 Nuwamba 2016

stated in ^Turanci

CAS Common Chemistry ^Turanci

retrieved ^Turanci

7 Afirilu 2021

https://commonchemistry.cas.org/detail?cas_rn=52-86-8

InChIKey ^Turanci

ChemSpider ID ^Turanci

3438

1 reference

stated in ^Turanci

ChemSpider ^Turanci

ChemSpider ID ^Turanci

haloperidol (Turanci)

retrieved ^Turanci

19 Nuwamba 2016

PubChem CID ^Turanci

3559

2 references

stated in ^Turanci

PubChem ^Turanci

PubChem CID ^Turanci

haloperidol (Turanci)

retrieved ^Turanci

19 Nuwamba 2016

InChIKey ^Turanci

Reaxys registry number ^Turanci

331267

1 reference

stated in ^Turanci

ChEBI ^Turanci

ChEBI ID ^Turanci

haloperidol (Turanci)

retrieved ^Turanci

3 Oktoba 2016

ChEBI ID ^Turanci

5613

mapping relation type ^Turanci

exact match ^Turanci

2 references

stated in ^Turanci

ChEMBL ^Turanci

ChEMBL ID ^Turanci

HALOPERIDOL (Turanci)

retrieved ^Turanci

19 Nuwamba 2016

InChI=1S/C21H23ClFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,26H,1-2,11-15H2

International Chemical Identifier ^Turanci

InChI ^Turanci

ChEMBL ID ^Turanci

CHEMBL54

1 reference

stated in ^Turanci

ChEMBL ^Turanci

ChEMBL ID ^Turanci

HALOPERIDOL (Turanci)

retrieved ^Turanci

19 Nuwamba 2016

SureChEMBL ID ^Turanci

SCHEMBL8264

2 references

based on heuristic ^Turanci

inferred from InChIKey ^Turanci

InChIKey ^Turanci

MSBNK-Athens_Univ-AU112201

UniChem compound ID ^Turanci

595399

1 reference

stated in ^Turanci

UniChem ^Turanci

MassBank accession ID ^Turanci

0 references

MSBNK-Athens_Univ-AU112202

0 references

MSBNK-Athens_Univ-AU112203

0 references

MSBNK-Athens_Univ-AU112204

0 references

MSBNK-Athens_Univ-AU112205

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

MSBNK-Waters-WA002247

0 references

MSBNK-Waters-WA002248

0 references

MSBNK-Waters-WA002249

0 references

MSBNK-Waters-WA002250

0 references

MSBNK-Waters-WA002251

0 references

SPLASH ^Turanci

splash10-00or-0409000000-d542c35143556b83b87a

0 references

splash10-014i-0900000000-3985dded029c89448ebe

0 references

splash10-01b9-0900000000-720c0a4f1130b4237f32

0 references

splash10-00di-0900000000-772a799ebb3b949cef0c

0 references

splash10-004i-0009000000-21c8918254235e561129

0 references

splash10-014i-0904000000-8c97cb39f9680dd91378

0 references

splash10-01b9-0900000000-571a03ebb5faa3e5cd63

0 references

splash10-00di-0900000000-62e233fd691121c78e96

0 references

splash10-00di-0900000000-91bf80d34ef94ed709f0

0 references

splash10-00di-0900000000-46ef29917220709863a4

0 references

splash10-00di-3900000000-26f391756d439f7dbfc8

0 references

splash10-00b9-9600000000-404fc399b40cfb560a99

0 references

splash10-00b9-9100000000-8779758823471091566a

0 references

splash10-004i-1619000000-27aa28ad7f91429f5ae7

0 references

splash10-0079-3290000000-cc6a990404ba7b9452a8

0 references

NMRShiftDB structure ID ^Turanci

20207509

1 reference

InChIKey ^Turanci

HSDB ID ^Turanci

3093

1 reference

stated in ^Turanci

Hazardous Substances Data Bank ^Turanci

HSDB ID ^Turanci

3093

ranar wallafa

28 Oktoba 2019

HALOPERIDOL (Turanci)

retrieved ^Turanci

10 Mayu 2021

DSSTox substance ID ^Turanci

DTXSID4034150

2 references

stated in ^Turanci

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard ^Turanci

InChIKey ^Turanci

DSSTOX compound identifier ^Turanci

DTXCID2014150

0 references

LiverTox ID ^Turanci

Haloperidol

0 references

NSC number ^Turanci

170973

0 references

757054

0 references

EC number ^Turanci

200-155-6

1 reference

stated in ^Turanci

UNII ^Turanci

haloperidol (Turanci)

retrieved ^Turanci

19 Nuwamba 2016

ECHA Substance Infocard ID ^Turanci

100.000.142

1 reference

stated in ^Turanci

ECHA Substance Infocard database ^Turanci

ECHA Substance Infocard ID ^Turanci

100.000.142

retrieved ^Turanci

27 Disamba 2018

Haloperidol (Turanci)

quotation ^Turanci

CAS no.: 52-86-8 (Turanci)

AICS Chemical ID (BEING DELETED) ^Turanci

462

0 references

Lambar ATC

N05AD01

1 reference

stated in ^Turanci

DrugBank ^Turanci

DrugBank ID ^Turanci

Haloperidol (Turanci)

ranar wallafa

17 Nuwamba 2015

World Health Organisation international non-proprietary name numeric ID ^Turanci

918

0 references

1 reference

stated in ^Turanci

haloperidol (Turanci)

retrieved ^Turanci

19 Nuwamba 2016

MeSH descriptor ID ^Turanci

subject named as ^Turanci

Haloperidol

0 references

MeSH concept ID ^Turanci

M0009771

0 references

Lambar itace MeSH

D02.522.352.506

0 references

RxNorm ID ^Turanci

5093

1 reference

stated in ^Turanci

UNII ^Turanci

haloperidol (Turanci)

retrieved ^Turanci

19 Nuwamba 2016

DrugBank ID ^Turanci

DB00502

1 reference

InChIKey ^Turanci

Human Metabolome Database ID ^Turanci

HMDB0014645

2 references

based on heuristic ^Turanci

inferred from InChIKey ^Turanci

InChIKey ^Turanci

UNII ^Turanci

J6292F8L3D

2 references

stated in ^Turanci

UNII ^Turanci

haloperidol (Turanci)

retrieved ^Turanci

19 Nuwamba 2016

InChIKey ^Turanci

MedlinePlus drug identifier ^Turanci

a682180

route of administration ^Turanci

oral administration ^Turanci

0 references

a615023

route of administration ^Turanci

intramuscular injection ^Turanci

0 references

NDF-RT ID ^Turanci

1 reference

stated in ^Turanci

UNII ^Turanci

haloperidol (Turanci)

retrieved ^Turanci

19 Nuwamba 2016

Probes And Drugs ID ^Turanci

PD002312

0 references

DrugCentral ID ^Turanci

1353

1 reference

stated in ^Turanci

UniChem ^Turanci

KEGG ID ^Turanci

C01814

1 reference

stated in ^Turanci

ChEBI ^Turanci

ChEBI ID ^Turanci

haloperidol (Turanci)

retrieved ^Turanci

3 Oktoba 2016

D00136

1 reference

stated in ^Turanci

ChEBI ^Turanci

ChEBI ID ^Turanci

haloperidol (Turanci)

retrieved ^Turanci

3 Oktoba 2016

PDB ligand ID ^Turanci

GMJ

0 references

CA PROP 65 ID ^Turanci

1 reference

stated in ^Turanci

California Proposition 65 list of chemicals ^Turanci

retrieved ^Turanci

6 Janairu 2020

https://oehha.ca.gov/chemicals/haloperidol

electronic Essential Medicines List medicine ID ^Turanci

25

1 reference

https://list.essentialmeds.org/medicines/25

eEML - Electronic Essential Medicines List (Turanci)

retrieved ^Turanci

23 Oktoba 2021

Elhuyar ZTH ID ^Turanci

024912

0 references

Encyclopædia Britannica Online ID ^Turanci

science/haloperidol

subject named as ^Turanci

haloperidol

0 references

Freebase ID ^Turanci

/m/0199v_

1 reference

stated in ^Turanci

Freebase Data Dumps ^Turanci

ranar wallafa

28 Oktoba 2013

Gran Enciclopèdia Catalana ID ^Turanci

0 references

Gran Enciclopèdia Catalana ID (former scheme) ^Turanci

0113487

0 references

J-GLOBAL ID ^Turanci

200907040481182796

0 references

Microsoft Academic ID ^Turanci

2780948584

0 references

NALT ID ^Turanci

10297

0 references

NCI Drug Dictionary ID ^Turanci

0 references

Nikkaji ID ^Turanci

J1.365J

0 references

OpenAlex ID ^Turanci

C2780948584

1 reference

stated in ^Turanci

OpenAlex ^Turanci

retrieved ^Turanci

26 Janairu 2022

https://docs.openalex.org/download-snapshot/snapshot-data-format

Quora topic ID ^Turanci

Haloperidol

1 reference

stated in ^Turanci

Quora ^Turanci

ScienceDirect topic ID ^Turanci

biochemistry-genetics-and-molecular-biology/haloperidol

0 references

Store medisinske leksikon ID ^Turanci

0 references

UK Parliament thesaurus ID ^Turanci

540051

subject named as ^Turanci

Haloperidol

0 references

UMLS CUI ^Turanci

C0018546

1 reference

stated in ^Turanci